Abnormal rearrangement within the alpha/delta T-cell receptor locus in lymphomas from Atm-deficient mice - PubMed (original) (raw)
. 2000 Sep 1;96(5):1940-6.
Affiliations
- PMID: 10961898
Free article
Abnormal rearrangement within the alpha/delta T-cell receptor locus in lymphomas from Atm-deficient mice
M Liyanage et al. Blood. 2000.
Free article
Abstract
Atm-deficient mice (Atm(-/-)) recapitulate many aspects of the ataxia telangiectasia (AT) syndrome, including the susceptibility to tumors of lymphoid origin. To investigate the mechanism of tumorigenesis, we have examined a panel of 8 thymic lymphomas from Atm(-/-) mice. All Atm(-/-) tumors are of thymic lymphoblastoid origin, display an immature CD3(-) and CD4(+)/CD8(+) phenotype, and arise coincident with V(D)J recombination. Cytogenetically, all tumors are diploid or near diploid but exhibit multiple chromosome aberrations with an average of 4 abnormal chromosomes per tumor. All the tumors revealed chromosome 14 rearrangements precisely at the T-cell receptoralpha/delta (Tcralpha/delta) locus, suggesting the involvement of V(D)J recombination in these translocations. In addition, 11.5% of Atm(-/-) peripheral T cells showed chromosome 14 translocations, suggesting that rearrangements at the Tcralpha/delta locus occur early during tumor development in the absence of ATM. However, additional genetic aberrations are required for tumorigenesis. For example, translocations involving chromosome 12, often with chromosome 14 (more than 60%), and partial or complete trisomy of chromosome 15, with copy number increases of the c-myc oncogene were frequently observed. These observations suggest that ATM is required for normal rearrangement of the Tcralpha/delta locus but not for V(D)J recombination at other loci. The mechanisms that lead to tumorigenesis may be due to the involvement of ATM in monitoring double-stranded DNA breaks. (Blood. 2000;96:1940-1946)
Similar articles
- Mechanisms Underlying the Suppression of Chromosome Rearrangements by Ataxia-Telangiectasia Mutated.
Yamauchi M. Yamauchi M. Genes (Basel). 2021 Aug 10;12(8):1232. doi: 10.3390/genes12081232. Genes (Basel). 2021. PMID: 34440406 Free PMC article. Review. - ATM-deficient thymic lymphoma is associated with aberrant tcrd rearrangement and gene amplification.
Zha S, Bassing CH, Sanda T, Brush JW, Patel H, Goff PH, Murphy MM, Tepsuporn S, Gatti RA, Look AT, Alt FW. Zha S, et al. J Exp Med. 2010 Jul 5;207(7):1369-80. doi: 10.1084/jem.20100285. Epub 2010 Jun 21. J Exp Med. 2010. PMID: 20566716 Free PMC article. - Aberrant TCRδ rearrangement underlies the T-cell lymphocytopenia and t(12;14) translocation associated with ATM deficiency.
Jiang W, Lee BJ, Li C, Dubois RL, Gostissa M, Alt FW, Zha S. Jiang W, et al. Blood. 2015 Apr 23;125(17):2665-8. doi: 10.1182/blood-2015-01-622621. Epub 2015 Feb 26. Blood. 2015. PMID: 25721125 Free PMC article. - RAG-mediated V(D)J recombination is not essential for tumorigenesis in Atm-deficient mice.
Petiniot LK, Weaver Z, Vacchio M, Shen R, Wangsa D, Barlow C, Eckhaus M, Steinberg SM, Wynshaw-Boris A, Ried T, Hodes RJ. Petiniot LK, et al. Mol Cell Biol. 2002 May;22(9):3174-7. doi: 10.1128/MCB.22.9.3174-3177.2002. Mol Cell Biol. 2002. PMID: 11940674 Free PMC article. - Leukemia and lymphoma in ataxia telangiectasia.
Taylor AM, Metcalfe JA, Thick J, Mak YF. Taylor AM, et al. Blood. 1996 Jan 15;87(2):423-38. Blood. 1996. PMID: 8555463 Review.
Cited by
- Prognostic Role of DNA Damage Response Genes Mutations and their Association With the Sensitivity of Olaparib in Prostate Cancer Patients.
Zhang D, Xu X, Wei Y, Chen X, Li G, Lu Z, Zhang X, Ren X, Wang S, Qin C. Zhang D, et al. Cancer Control. 2022 Jan-Dec;29:10732748221129451. doi: 10.1177/10732748221129451. Cancer Control. 2022. PMID: 36283420 Free PMC article. - Mechanisms Underlying the Suppression of Chromosome Rearrangements by Ataxia-Telangiectasia Mutated.
Yamauchi M. Yamauchi M. Genes (Basel). 2021 Aug 10;12(8):1232. doi: 10.3390/genes12081232. Genes (Basel). 2021. PMID: 34440406 Free PMC article. Review. - FATC Domain Deletion Compromises ATM Protein Stability, Blocks Lymphocyte Development, and Promotes Lymphomagenesis.
Milanovic M, Shao Z, Estes VM, Wang XS, Menolfi D, Lin X, Lee BJ, Xu J, Cupo OM, Wang D, Zha S. Milanovic M, et al. J Immunol. 2021 Mar 15;206(6):1228-1239. doi: 10.4049/jimmunol.2000967. Epub 2021 Feb 3. J Immunol. 2021. PMID: 33536256 Free PMC article. - Endogenous topoisomerase II-mediated DNA breaks drive thymic cancer predisposition linked to ATM deficiency.
Álvarez-Quilón A, Terrón-Bautista J, Delgado-Sainz I, Serrano-Benítez A, Romero-Granados R, Martínez-García PM, Jimeno-González S, Bernal-Lozano C, Quintero C, García-Quintanilla L, Cortés-Ledesma F. Álvarez-Quilón A, et al. Nat Commun. 2020 Feb 14;11(1):910. doi: 10.1038/s41467-020-14638-w. Nat Commun. 2020. PMID: 32060399 Free PMC article. - ATM, ATR and DNA-PKcs kinases-the lessons from the mouse models: inhibition ≠ deletion.
Menolfi D, Zha S. Menolfi D, et al. Cell Biosci. 2020 Jan 29;10:8. doi: 10.1186/s13578-020-0376-x. eCollection 2020. Cell Biosci. 2020. PMID: 32015826 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials
Miscellaneous